SecBot SecBot
SECBOTREPLAY Home › Report › MRKR

MRKR · Marker Therapeutics is holding its 2026 annual meeting where…

Marker Therapeutics, Inc. · DEFA14A filed Mar 20, 2026 at 16:08 ET

At the news

NEUTRALIMPACT 4/10

DEFA14A filed Mar 20, 2026 at 16:08 ET

Marker Therapeutics is holding its 2026 annual meeting where shareholders will vote on several proposals, including the election of directors, approval of executive compensation, and a critical proposal to increase authorized shares from 30 million to 130 million. The company is also seeking ratification of its auditors and approval to adjourn the meeting if needed to secure votes for the share increase.

  • Annual meeting scheduled for May 1, 2026.
  • Proposal 3 seeks to increase authorized common stock from 30 million to 130 million shares.
  • The company is asking for approval to adjourn the meeting (Proposal 6) if there are insufficient votes for the share increase.
  • Board recommends voting 'FOR' on all proposals.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access